ARTICLE | Company News
Abcodia, Cancer Research U.K. deal
June 10, 2013 7:00 AM UTC
Cancer Research U.K. and its Cancer Research Technology Ltd. (CRT) commercial arm partnered with Abcodia to develop blood tests to detect a range of cancers when they are still early stage and asymptomatic. Abcodia and CRT will jointly commercialize any biomarkers discovered during the deal and share revenues resulting from potential licensing deals with additional parties. The three partners will seek additional academic and commercial partners to discover, validate and further develop any biomarkers. ...